Annual EBITDA
$311.81 M
+$94.92 M+43.76%
December 31, 2023
Summary
- As of February 7, 2025, SBRA annual EBITDA is $311.81 million, with the most recent change of +$94.92 million (+43.76%) on December 31, 2023.
- During the last 3 years, SBRA annual EBITDA has fallen by -$104.48 million (-25.10%).
- SBRA annual EBITDA is now -49.76% below its all-time high of $620.61 million, reached on December 31, 2018.
Performance
SBRA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$101.71 M
+$6.30 M+6.61%
September 30, 2024
Summary
- As of February 7, 2025, SBRA quarterly EBITDA is $101.71 million, with the most recent change of +$6.30 million (+6.61%) on September 30, 2024.
- Over the past year, SBRA quarterly EBITDA has increased by +$44.96 million (+79.22%).
- SBRA quarterly EBITDA is now -64.31% below its all-time high of $284.98 million, reached on June 30, 2018.
Performance
SBRA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$383.61 M
+$44.96 M+13.28%
September 30, 2024
Summary
- As of February 7, 2025, SBRA TTM EBITDA is $383.61 million, with the most recent change of +$44.96 million (+13.28%) on September 30, 2024.
- Over the past year, SBRA TTM EBITDA has increased by +$167.27 million (+77.31%).
- SBRA TTM EBITDA is now -48.67% below its all-time high of $747.36 million, reached on September 30, 2018.
Performance
SBRA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SBRA EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +43.8% | +79.2% | +77.3% |
3 y3 years | -25.1% | +116.7% | +130.8% |
5 y5 years | -49.8% | +116.7% | +130.8% |
SBRA EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +87.6% | -8.5% | +1553.2% | at high | +130.8% |
5 y | 5-year | -25.1% | +87.6% | -9.4% | +260.7% | -20.5% | +130.8% |
alltime | all time | -49.8% | +347.0% | -64.3% | +260.7% | -48.7% | +2469.2% |
Sabra Health Care REIT EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $101.71 M(+6.6%) | $383.61 M(+13.3%) |
Jun 2024 | - | $95.41 M(-2.7%) | $338.65 M(+0.4%) |
Mar 2024 | - | $98.03 M(+10.8%) | $337.23 M(+8.2%) |
Dec 2023 | $311.81 M(+43.8%) | $88.47 M(+55.9%) | $311.81 M(+44.1%) |
Sep 2023 | - | $56.75 M(-39.6%) | $216.34 M(+17.2%) |
Jun 2023 | - | $93.98 M(+29.4%) | $184.61 M(+3.5%) |
Mar 2023 | - | $72.61 M(-1137.4%) | $178.38 M(-17.8%) |
Dec 2022 | $216.89 M(+30.5%) | -$7.00 M(-128.0%) | $216.89 M(-19.9%) |
Sep 2022 | - | $25.01 M(-71.5%) | $270.82 M(-16.8%) |
Jun 2022 | - | $87.76 M(-21.0%) | $325.41 M(+86.6%) |
Mar 2022 | - | $111.11 M(+136.8%) | $174.36 M(+4.9%) |
Dec 2021 | $166.21 M(-60.1%) | $46.93 M(-41.0%) | $166.21 M(-25.9%) |
Sep 2021 | - | $79.60 M(-225.8%) | $224.45 M(-10.3%) |
Jun 2021 | - | -$63.29 M(-161.5%) | $250.28 M(-39.4%) |
Mar 2021 | - | $102.97 M(-2.1%) | $413.12 M(-0.8%) |
Dec 2020 | $416.29 M(+9.4%) | $105.17 M(-0.2%) | $416.29 M(-1.7%) |
Sep 2020 | - | $105.44 M(+5.9%) | $423.43 M(+2.2%) |
Jun 2020 | - | $99.55 M(-6.2%) | $414.45 M(-14.1%) |
Mar 2020 | - | $106.13 M(-5.5%) | $482.52 M(+26.8%) |
Dec 2019 | $380.58 M(-38.7%) | $112.31 M(+16.4%) | $380.58 M(+13.5%) |
Sep 2019 | - | $96.46 M(-42.5%) | $335.35 M(-8.4%) |
Jun 2019 | - | $167.62 M(+3903.4%) | $366.19 M(-24.3%) |
Mar 2019 | - | $4.19 M(-93.8%) | $483.55 M(-22.8%) |
Dec 2018 | $620.61 M(+71.8%) | $67.08 M(-47.3%) | $626.17 M(-16.2%) |
Sep 2018 | - | $127.29 M(-55.3%) | $747.36 M(+8.9%) |
Jun 2018 | - | $284.98 M(+94.1%) | $686.08 M(+50.8%) |
Mar 2018 | - | $146.81 M(-22.0%) | $454.85 M(+25.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2017 | $361.34 M(+76.6%) | $188.27 M(+185.2%) | $361.98 M(+57.3%) |
Sep 2017 | - | $66.01 M(+22.8%) | $230.07 M(+3.4%) |
Jun 2017 | - | $53.75 M(-0.3%) | $222.42 M(-6.9%) |
Mar 2017 | - | $53.94 M(-4.3%) | $238.96 M(+17.2%) |
Dec 2016 | $204.60 M(+1.1%) | $56.37 M(-3.4%) | $203.97 M(-1.8%) |
Sep 2016 | - | $58.36 M(-17.0%) | $207.67 M(+4.4%) |
Jun 2016 | - | $70.30 M(+271.1%) | $198.82 M(+14.3%) |
Mar 2016 | - | $18.94 M(-68.5%) | $173.90 M(-14.1%) |
Dec 2015 | $202.43 M(+47.5%) | $60.07 M(+21.3%) | $202.43 M(+4.7%) |
Sep 2015 | - | $49.52 M(+9.1%) | $193.35 M(+6.6%) |
Jun 2015 | - | $45.38 M(-4.4%) | $181.34 M(+5.7%) |
Mar 2015 | - | $47.47 M(-6.9%) | $171.50 M(+25.0%) |
Dec 2014 | $137.20 M(+27.7%) | $50.99 M(+36.0%) | $137.20 M(+15.9%) |
Sep 2014 | - | $37.50 M(+5.5%) | $118.34 M(+6.9%) |
Jun 2014 | - | $35.55 M(+170.0%) | $110.66 M(+19.2%) |
Mar 2014 | - | $13.16 M(-59.0%) | $92.81 M(-13.6%) |
Dec 2013 | $107.46 M(+27.8%) | $32.13 M(+7.8%) | $107.46 M(+11.0%) |
Sep 2013 | - | $29.82 M(+68.4%) | $96.85 M(+9.0%) |
Jun 2013 | - | $17.70 M(-36.3%) | $88.83 M(-4.0%) |
Mar 2013 | - | $27.80 M(+29.2%) | $92.51 M(+10.0%) |
Dec 2012 | $84.11 M(+20.6%) | $21.52 M(-1.3%) | $84.11 M(-0.7%) |
Sep 2012 | - | $21.81 M(+2.0%) | $84.71 M(+6.3%) |
Jun 2012 | - | $21.38 M(+10.2%) | $79.72 M(+7.4%) |
Mar 2012 | - | $19.41 M(-12.3%) | $74.23 M(+6.4%) |
Dec 2011 | $69.75 M | $22.12 M(+31.5%) | $69.75 M(+46.4%) |
Sep 2011 | - | $16.82 M(+5.9%) | $47.63 M(+54.6%) |
Jun 2011 | - | $15.88 M(+6.4%) | $30.81 M(+106.4%) |
Mar 2011 | - | $14.93 M | $14.93 M |
FAQ
- What is Sabra Health Care REIT annual EBITDA?
- What is the all time high annual EBITDA for Sabra Health Care REIT?
- What is Sabra Health Care REIT annual EBITDA year-on-year change?
- What is Sabra Health Care REIT quarterly EBITDA?
- What is the all time high quarterly EBITDA for Sabra Health Care REIT?
- What is Sabra Health Care REIT quarterly EBITDA year-on-year change?
- What is Sabra Health Care REIT TTM EBITDA?
- What is the all time high TTM EBITDA for Sabra Health Care REIT?
- What is Sabra Health Care REIT TTM EBITDA year-on-year change?
What is Sabra Health Care REIT annual EBITDA?
The current annual EBITDA of SBRA is $311.81 M
What is the all time high annual EBITDA for Sabra Health Care REIT?
Sabra Health Care REIT all-time high annual EBITDA is $620.61 M
What is Sabra Health Care REIT annual EBITDA year-on-year change?
Over the past year, SBRA annual EBITDA has changed by +$94.92 M (+43.76%)
What is Sabra Health Care REIT quarterly EBITDA?
The current quarterly EBITDA of SBRA is $101.71 M
What is the all time high quarterly EBITDA for Sabra Health Care REIT?
Sabra Health Care REIT all-time high quarterly EBITDA is $284.98 M
What is Sabra Health Care REIT quarterly EBITDA year-on-year change?
Over the past year, SBRA quarterly EBITDA has changed by +$44.96 M (+79.22%)
What is Sabra Health Care REIT TTM EBITDA?
The current TTM EBITDA of SBRA is $383.61 M
What is the all time high TTM EBITDA for Sabra Health Care REIT?
Sabra Health Care REIT all-time high TTM EBITDA is $747.36 M
What is Sabra Health Care REIT TTM EBITDA year-on-year change?
Over the past year, SBRA TTM EBITDA has changed by +$167.27 M (+77.31%)